Related Experiment Video
Updated: Jan 7, 2026

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
Published on: August 17, 2016
Non-cytotoxic, iodinated poly(ethylene oxide) (PEO) block-co-polymer contrast agents for computed tomography (CT)
Mayson Whipple1, Barbara Christian2, Kendell M Pawelec3,4
1Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA. ferrier5@msu.edu.
None:
Medical imaging techniques like X-ray, magnetic resonance imaging (MRI), and computed tomography (CT) rely on contrast agents to enhance the visibility of blood vessels, tissues, and organs, making them crucial for medical diagnoses. Contrast agents used clinically for CT are typically small molecules containing iodine, which are associated with nephrotoxicity, often require large doses that can disrupt thyroid function, have short half-lives, and are sometimes immunogenic. Loading/functionalization of larger molecules with iodine may attenuate X-rays similarly to small molecules, but at much lower concentrations, potentially mitigating the adverse effects of current contrast agents. To test this, iodinated poly(ethylene oxide) (PEO) was synthesized with varying amounts of iodine and structural features and examined for use as a contrast agent. First, 5 kg mol-1 PEG containing one terminal hydroxyl was reacted with trimethylaluminum to form a macroinitiator from which block-co-polymers consisting of PEO-co-poly(epichlorohydrin) (PECH) were synthesized with PECH blocks of 5, 15, and 30 kg mol-1. The polymers were subsequently iodinated and characterized with 1H NMR and 13C NMR spectroscopy, size exclusion chromatography (SEC), and differential scanning calorimetry (DSC). X-Ray attenuation was found to be similar to that of iohexol, a conventional contrast agent. Further, we found that high molecular weight polymers were completely non-cytotoxic, unlike iohexol, with polymer size the dominating factor for cytotoxicity rather than iodine concentration. As such, these new materials hold promise as medical contrast agents.
More Related Videos
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
Imaging Studies III: Computed Tomography
Radiological Investigation I: X-ray and CT
Imaging Studies for Cardiovascular System V: CT
Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Depolarizing Blockers: Pharmocokinetics